# CVM GFI #100 (VICH GL18 (R2)) Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substances and Excipients (Revision 2) - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-100-vich-gl18-r2-impurities-residual-solvents-in-new-veterinary-medicinal-products-active-substances-and-excipients-revision-2/c0564c1d-25bb-407e-ac8b-f7bc0de58f8c

> FDA guidance document: CVM GFI #100 (VICH GL18 (R2)) Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substances and Excipients (Revision 2). Issue date: July 25, 2024. Get complete insights and analysis.

---

## Details

- Title: CVM GFI #100 (VICH GL18 (R2)) Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substances and Excipients (Revision 2)
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Veterinary Medicine
- Office URL: /offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
- Issue Date: 2024-07-25
- Comment Close Date: 2022-09-16
- Last Changed: 2024-07-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-2955 ">FDA-1999-D-2955 </a>

## Related Documents

- [CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-286-vich-gl60-good-manufacturing-practice-for-active-pharmaceutical-ingredients-used-in-veterinary-medicinal-products/7f7052eb-5fa4-4d38-b174-a5a3f7b63abc)
- [CVM GFI #290 (VICH GL61) – Pharmaceutical Development](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-290-vich-gl61-pharmaceutical-development/e8fd92df-cd71-4f54-be38-a00b312eecbb)
- [CVM GFI #264 Standardized Medicated Feed Assay Limits](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-264-standardized-medicated-feed-assay-limits/2cc97c03-a52f-438a-816f-e73486d935d4)